Novel oral anticoagulation treatment is not associated with recurrent or severe epistaxis

Rhinology. 2021 Apr 1;59(2):219-221. doi: 10.4193/Rhin20.541.

Authors

D Runggaldier¹, V Schindler², Y Luo³, T Kleinjung³, M B Soyka³

Affiliations

¹ Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, Switzerland;University of Zurich, Switzerland.
² University of Zurich, Switzerland;Division of Gastroenterology and Hepatology, University Hospital Zurich, Switzerland.
³ Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, Switzerland; University of Zurich, Switzerland.

PMID: 33377891
DOI: 10.4193/Rhin20.541

No abstract available

MeSH terms

Administration, Oral
Anticoagulants* / adverse effects
Epistaxis* / chemically induced
Epistaxis* / drug therapy
Humans
Recurrence

Substances

Anticoagulants